ArticleBiomedical engineering online2025
Evaluating cell viability assessment techniques: a comparative study of flow cytometry and fluorescence microscopy in response to bioactive glass exposure.
Article in Biomedical engineering online, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In situ detection of dead cells from live cells via a DC plus low frequency AC resistive pulse sensor.Biomedical microdevices · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Reliable in vitro cytotoxicity assessment of biomaterials is essential for preclinical evaluation. Fluorescence microscopy (FM) and flow cytometry (FCM) are widely used methods, yet their comparative performance in particulate systems remains underexplored. This study compares FM and FCM in evaluating the cytotoxicity of Bioglass 45S5 (BG) on SAOS-2 osteoblast-like cells across different particle sizes and concentrations. The cells were treated with BG particles in three size ranges (< 38 µm, 63-125 µm, and 315-500 µm) at concentrations of 25, 50, and 100 mg/mL for 3 and 72 h. FM employs FDA/PI staining to distinguish viable and nonviable cells, whereas FCM utilizes multiparametric staining (Hoechst, DiIC1, Annexin V-FITC, and PI) to classify viable, apoptotic, and necrotic populations. Both techniques confirmed a clear trend: smaller particles and higher concentrations caused greater cytotoxicity. The most pronounced effect was observed for < 38 µm particles at 100 mg/mL, which reduced FM-assessed viability to 9% at 3 h and 10% at 72 h; FCM measurements under the same conditions revealed 0.2% and 0.7% viability, respectively. The controls retained > 97% viability, indicating size-based cytotoxicity. A strong correlation between FM and FCM data (r = 0.94, R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.